Enhanced diagnostic and prognostic assessment of cardiac amyloidosis using combined 11C-PiB PET/CT and 99mTc-DPD scintigraphy
Zhihui Hong(Vienna General Hospital), Xiang Li(Scripps Research Institute), Stefan Grünert(Vienna General Hospital), Raffaella Calabretta(Vienna General Hospital), Christian Nitsche(Medical University of Vienna), Kilian Kluge(Vienna General Hospital), Marcus Hacker(Medical University of Vienna), Song Xue(Shanxi Medical University), Zewen Jiang(Vienna General Hospital), Clemens P. Spielvogel(Christian Doppler Laboratory for Thermoelectricity), David Haberl(Vienna General Hospital), Josef Yu(Medical University of Vienna)
European Journal of Nuclear Medicine and Molecular Imaging
February 28, 2025
Cited by 11
Related Papers
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Biochar supported nanoscale zerovalent iron composite used as persulfate activator for removing trichloroethylene
|Bioresource Technology|2014|600
Cartilage-targeting peptide-modified dual-drug delivery nanoplatform with NIR laser response for osteoarthritis therapy
|Bioactive Materials|2021|203
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy
|Journal of the American College of Cardiology|2024|137
Light-Chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and Outcome
|European Journal of Heart Failure|2020|130